AGA is seeking public comments for two new quality measure specifications on the testing, treating and eradication of the hepatitis c virus (HCV). For your first look at these quality measures, visit the link below and submit your feedback by completing the survey. Submit your comments by June 23.
Measure specifications for review
About AGA’s quality measures
AGA has been instrumental in assuring that GI has a place at the table concerning quality, influencing the national agenda through developing, specifying, maintaining, testing and implementing quality measures, and through membership and participation in the Core Quality Measures Collaborative (CQMC), the Centers for Medicare and Medicaid Services (CMS) Quality Payment Program and other national organizations.
The AGA Institute Quality Committee (QC) provides clinical and methodological expertise and oversight for the development, specification, maintenance and testing of AGA’s performance measures.
AGA follows a process for prioritizing and developing measures from AGA guidelines. Periodically, the AGA Quality Committee issues calls for new measure topics of interest to AGA members, however AGA primarily develops quality measures from AGA Guidelines following the GRADE approach. Public comment periods are held to receive feedback from gastroenterologists and other stakeholders who are interested in new AGA measures.